Literature DB >> 30498055

The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) ERS Clinical Research Collaboration.

Stefano Aliberti1, Eva Polverino2, James D Chalmers3, Josje Altenburg4, Michal Shteinberg5, Pieter C Goeminne6,7, Tobias Welte8, Amelia Shoemark3, Marta Almagro9, Francesco Blasi1.   

Abstract

Mesh:

Year:  2018        PMID: 30498055     DOI: 10.1183/13993003.02074-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  8 in total

1.  The Primary Ciliary Dyskinesia Computed Tomography Score in Adults with Bronchiectasis: A Derivation und Validation Study.

Authors:  Jessica Rademacher; Sabine Dettmer; Jan Fuge; Jens Vogel-Claussen; Hoen-Oh Shin; Anand Shah; Paula Inês Pedro; Rob Wilson; Tobias Welte; Frank Wacker; Michael R Loebinger; Felix C Ringshausen
Journal:  Respiration       Date:  2021-04-23       Impact factor: 3.580

2.  Recommendations for travelling with bronchiectasis: a joint ELF/EMBARC/ERN-Lung collaboration.

Authors:  Michal Shteinberg; Barbara Crossley; Tal Lavie; Sima Nadler; Jeanette Boyd; Felix C Ringshausen; Tim Aksamit; James D Chalmers; Pieter Goeminne
Journal:  ERJ Open Res       Date:  2019-10-30

Review 3.  The importance of effective registries in pulmonary diseases and how to optimize their output.

Authors:  Joanna Chorostowska-Wynimko; Marion Wencker; Ildikó Horváth
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

4.  Risk factors for the development of bronchiectasis in patients with asthma.

Authors:  Donghai Ma; María-Jesús Cruz; Iñigo Ojanguren; Christian Romero-Mesones; Diego Varona-Porres; Xavier Munoz
Journal:  Sci Rep       Date:  2021-11-24       Impact factor: 4.379

5.  ROSE: radiology, obstruction, symptoms and exposure - a Delphi consensus definition of the association of COPD and bronchiectasis by the EMBARC Airways Working Group.

Authors:  Letizia Traversi; Marc Miravitlles; Miguel Angel Martinez-Garcia; Michal Shteinberg; Apostolos Bossios; Katerina Dimakou; Joseph Jacob; John R Hurst; Pier Luigi Paggiaro; Sebastian Ferri; Georgios Hillas; Jens Vogel-Claussen; Sabine Dettmer; Stefano Aliberti; James D Chalmers; Eva Polverino
Journal:  ERJ Open Res       Date:  2021-11-22

6.  The disease-specific clinical trial network for primary ciliary dyskinesia: PCD-CTN.

Authors:  Johanna Raidt; Bernard Maitre; Petra Pennekamp; Josje Altenburg; Pinelopi Anagnostopoulou; Miguel Armengot; Lizan D Bloemsma; Mieke Boon; Melissa Borrelli; Folke Brinkmann; Siobhan B Carr; Mary P Carroll; Silvia Castillo-Corullón; André Coste; Renato Cutrera; Eleonora Dehlink; Damien M S Destouches; Maria E Di Cicco; Lucy Dixon; Nagehan Emiralioglu; Ela Erdem Eralp; Eric G Haarman; Claire Hogg; Bulent Karadag; Helene E Kobbernagel; Natalie Lorent; Marcus A Mall; June K Marthin; Vendula Martinu; Manjith Narayanan; Ugur Ozcelik; Daniel Peckham; Massimo Pifferi; Petr Pohunek; Eva Polverino; Simon Range; Felix C Ringshausen; Evie Robson; Jobst Roehmel; Sandra Rovira-Amigo; Francesca Santamaria; Anne Schlegtendal; Zsolt Szépfalusi; Petra Tempels; Guillaume Thouvenin; Nicola Ullmann; Woolf T Walker; Martin Wetzke; Panayiotis Yiallouros; Heymut Omran; Kim G Nielsen
Journal:  ERJ Open Res       Date:  2022-08-15

7.  Non-tuberculous mycobacterial lung disease in patients with bronchiectasis: perceived risk, severity and guideline adherence in a European physician survey.

Authors:  Dirk Wagner; Jakko van Ingen; Roald van der Laan; Marko Obradovic
Journal:  BMJ Open Respir Res       Date:  2020-04

Review 8.  Bronchiectasis in Primary Antibody Deficiencies: A Multidisciplinary Approach.

Authors:  Luke A Wall; Elizabeth L Wisner; Kevin S Gipson; Ricardo U Sorensen
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.